Human Pathology
Volume 37, Issue 1 , Pages 16-22 , January 2006

Expression of survivin, p53, and caspase 3 in Barrett's esophagus carcinogenesis

  • Anna Parenti, MD

      Affiliations

    • Section of Pathologic Anatomy, Department of Oncological and Surgical Sciences, University of Padova, Padova 35100, Italy
    • ,
  • Genesio Leo, MD

      Affiliations

    • Section of Pathologic Anatomy, Department of Oncological and Surgical Sciences, University of Padova, Padova 35100, Italy
    • Corresponding Author InformationCorresponding author.
    • ,
  • Andrea Porzionato, MD

      Affiliations

    • Section of Anatomy, Department of Human Anatomy and Physiology, University of Padova, Padova 35100, Italy
    • ,
  • Giovanni Zaninotto, MD

      Affiliations

    • Department of Medical and Surgical Sciences, Clinica Chirurgica 3, University of Padova, Padova 35100, Italy
    • ,
  • Antonio Rosato, MD

      Affiliations

    • Section of Pathologic Anatomy, Department of Oncological and Surgical Sciences, University of Padova, Padova 35100, Italy
    • ,
  • Vito Ninfo, MD

      Affiliations

    • Section of Pathologic Anatomy, Department of Oncological and Surgical Sciences, University of Padova, Padova 35100, Italy

Received 23 June 2005 ,Revised 3 October 2005 ,Accepted 11 October 2005.

References 

  1. Crook NE, Clem RJ, Miller LK. An apoptosis-inhibiting baculovirus gene with a zinc finger-like motif. J Virol. 1993;67:2168–2174
  2. Li F, Ambrosiani G, Chu EY, et al. Control of apoptosis and mitotic spindle checkpoint by survivin. Nature. 1998;396:580–584
  3. Adida C, Berrebi D, Peuchmaur M, et al. Anti-apoptosis gene, survivin, and prognosis of neuroblastoma. Lancet. 1998;351:882–883
  4. Grabowski P, Kuhnel T, Muhr-Wilkenshoff F, et al. Prognostic value of nuclear survivin expression in esophageal squamous cell carcinoma. Br J Cancer. 2003;88:115–119
  5. Ikeguchi M, Yamaguchi K, Kaibara N. Survivin gene expression positively correlates with proliferative activity of cancer cells in esophageal cancer. Tumor Biol. 2003;24:40–45
  6. Lo Muzio L, Pannone G, Staibano S, et al. Survivin expression in oral squamous cell carcinoma. Br J Cancer. 2003;89:2244–2248
  7. Kawasaki H, Altieri DC, Lu CD, et al. Inhibition of apoptosis by survivin predicts shorter survival rates in colorectal cancer. Cancer Res. 1998;58:5071–5074
  8. Monzo M, Rosell R, Felip E, et al. A novel anti-apoptosis gene: re-expression of survivin messenger RNA as a prognosis marker in non–small-cell lung cancers. J Clin Oncol. 1999;17:2100–2104
  9. Tanaka K, Iwamoto S, Gon G, et al. Expression of survivin and its relationship to loss of apoptosis in breast carcinomas. Clin Cancer Res. 2000;6:127–134
  10. Frost M, Jarboe EA, Orlicky D, et al. Immunohistochemical localization of survivin in benign cervical mucosa, cervical dysplasia, and invasive squamous cell carcinoma. Am J Clin Pathol. 2002;117:738–744
  11. Gianani R, Jarboe E, Orlicky D, et al. Expression of survivin in normal, hyperplastic and neoplastic colonic mucosa. Hum Path. 2001;32:119–125
  12. Chiodino C, Cesinaro AM, Ottani D, et al. Communication: expression of the novel inhibitor of apoptosis survivin in normal and neoplastic skin. J Invest Dermatol. 1999;113:415–418
  13. Grossman D, McNiff JM, Li F, et al. Expression of the apoptosis inhibitor, survivin, in nonmelanoma skin cancer and gene targeting in a keratinocyte cell line. Lab Invest. 1999;79:1121–1126
  14. Lo Muzio L, Pannone G, Leonardi R, et al. Survivin, a potential early predictor of tumor progression in the oral mucosa. J Dent Res. 2003;82:923–928
  15. Lu CD, Altieri DC, Tanigawa N. Expression of a novel antiapoptosis gene, survivin, correlated with tumor cell apoptosis and p53 accumulation in gastric carcinomas. Cancer Res. 1998;58:1808–1812
  16. Parenti AR, Rugge M, Frizzera E, et al. p53 overexpression in the multistep process of oesophageal carcinogenesis. Am J Surg Pathol. 1995;19:1418–1422
  17. Lin LJ, Zheng CQ, Jin Y, et al. Expression of survivin protein in human colorectal carcinogenesis. World J Gastroenterol. 2003;9:974–977
  18. Li F, Yang J, Ramnath N, et al. Nuclear or cytoplasmic expression of survivin: what is the significance?. Int J Cancer. 2005;114:509–512
  19. Campomenosi P, Conio M, Bogliolo M, et al. p53 is frequently mutated in Barrett's metaplasia of the intestinal type. Cancer Epidemiol Biomarkers Prev. 1996;5:559–565
  20. Segal F, Kaspary AP, Prolla JC, et al. p53 protein overexpression and p53 mutation analysis in patients with intestinal metaplasia of the cardia and Barrett's esophagus. Cancer Lett. 2004;210:213–218
  21. Suspiro A, Pereira AD, Alfonso A, et al. Losses of heterozygosity on chromosomes 9p and 17p are frequent events in Barrett's metaplasia not associated with dysplasia or adenocarcinoma. Am J Gastroenterol. 2003;98:728–734
  22. Ramel S, Reid BJ, Sanchez CA, et al. Evaluation of p53 protein expression in Barrett's esophagus by two-parameter flow cytometry. Gastroenterology. 1992;102:1220–1228
  23. Younes M, Lebovitz RM, Lechago LV, et al. p53 protein accumulation in Barrett's metaplasia, dysplasia, and carcinoma: a follow-up study. Gastroenterology. 1993;105:1637–1642
  24. Krishnadath KK, Tilanus HW, van Blakenstein M, et al. Accumulation of p53 protein in normal, dysplastic and neoplastic Barrett's oesophagus. J Pathol. 1995;175:175–180
  25. Ferec C, Audrezet MP, Mercier B, et al. TP53 gene alterations during neoplastic progression of Barrett's mucosa. Gastroenterol Clin Biol. 1994;18:D46–D51
  26. Hardwick RH, Shepherd NA, Moorghen M, et al. Adenocarcinoma arising in Barrett's oesophagus: evidence for the participation of p53 dysfunction in the dysplasia/carcinoma sequence. Gut. 1994;35:764–768
  27. Levine DS. Barrett's oesophagus and p53. Lancet. 1994;344:212–213
  28. Blount PL, Galipeau PC, Sanchez CA, et al. 17p allelic losses in diploid cells of patients with Barrett's esophagus who develop aneuploidy. Cancer Res. 1994;54:2292–2295
  29. Neshat K, Sanchez CA, Galipeau PC, et al. p53 mutation in Barrett's adenocarcinoma and high-grade dysplasia. Gastroenterology. 1994;106:1589–1595
  30. Hoffman WH, Biade S, Zilfou JT, et al. Transcriptional repression of the anti-apoptotic survivin gene by wild type p53. J Biol Chem. 2002;277:3247–3257
  31. Mirza A, McGuirk M, Hockenberry TN, et al. Human survivin is negatively regulated by wild-type p53 and participates in p53-dependent apoptotic pathway. Oncogene. 2002;21:2613–2622
  32. Zhou M, Gu L, Li F, et al. DNA damage induces a novel p53-survivin signaling pathway regulating cell cycle and apoptosis in acute lymphoblastic leukemia cells. J Pharmacol Exp Ther. 2002;303:124–131
  33. Hsia JY, Chen CY, Chen JT, et al. Prognostic significance of caspase-3 expression in primary resected esophageal squamous cell carcinoma. EJSO. 2003;29:44–48
  34. Li YH, Wang C, Meng K, et al. Influence of survivin and caspase-3 on cell apoptosis and prognosis in gastric carcinoma. World J Gastroenterol. 2004;10:1984–1988
  35. Wang JX, Zheng S. Caspase-3 and survivin expression in pediatric neuroblastoma and their roles in apoptosis. Chin Med J. 2004;117:1821–1824
  36. Isobe N, Onodera H, Mori A, et al. Caspase-3 expression in human gastric carcinoma and its clinical significance. Oncology. 2004;66:201–209
  37. Estrov Z, Thall PF, Talpaz M, et al. Caspase 2 and caspase 3 protein levels as predictors of survival in acute myelogenous leukemia. Blood. 1998;92:3090–3097

PII: S0046-8177(05)00584-8

doi: 10.1016/j.humpath.2005.10.003

Human Pathology
Volume 37, Issue 1 , Pages 16-22 , January 2006

Article Tools

* Image Usage & Resolution